Tapewire

Nasdaq · USD

VBIO

Valion Bio, Inc.

Export transactions ↓
Tapewire entity
8459
SEC CIK
0001787740
Parsed reports
76

Last 12 months

Inside the activity.

2 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202620
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 08, 2023 Filed May 10, 2023 22:43 UTC
Gurfein BlakeChief Scientific Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 100,000 $0.00 Strike: $0.13 $0.00
Disclosure

SEC source: 0000899243-23-012533 · doc4.xml · derivative · entry 1

Gurfein Blake · CIK 0001891888 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2033-05-07

F1 · derivative.exercise_date: The option vests as follows: (i) 25% one year from the grant date, and (ii) the remaining 75% in equal monthly installments over the 36 months thereafter.

Read SEC document
June 14, 2022 Filed Jun 16, 2022 19:44 UTC
Zikria DeanDirector
GrantEmployee Stock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $1.75 $0.00
Disclosure

SEC source: 0001104659-22-072042 · tm2218712-1_4seq1.xml · derivative · entry 1

Zikria Dean · CIK 0001877611 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2032-06-13

F1 · derivative.exercise_date: The option vests as follows: (i) 50% one year from the grant date, and (ii) the remaining 50% in equal monthly installments over the next 24 months.

Read SEC document
June 14, 2022 Filed Jun 16, 2022 23:45 UTC GrantEmployee Stock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $1.75 $0.00
Disclosure

SEC source: 0001104659-22-072043 · tm2218712-2_4seq1.xml · derivative · entry 1

Bolton Sheryle · CIK 0001418947 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2032-06-13

F1 · derivative.exercise_date: The option vests as follows: (i) 50% one year from the grant date, and (ii) the remaining 50% in equal monthly installments over the next 24 months.

Read SEC document
June 14, 2022 Filed Jun 16, 2022 23:47 UTC GrantEmployee Stock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $1.75 $0.00
Disclosure

SEC source: 0001104659-22-072045 · tm2218712-3_4seq1.xml · derivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2032-06-13

F1 · derivative.exercise_date: The option vests as follows: (i) 50% one year from the grant date, and (ii) the remaining 50% in equal monthly installments over the next 24 months.

Read SEC document
June 14, 2022 Filed Jun 21, 2022 17:23 UTC Amendment
Zikria DeanDirector
GrantEmployee Stock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $1.75 $0.00
Disclosure

SEC source: 0001104659-22-073070 · tm2218957-1_4aseq1.xml · derivative · entry 1

Zikria Dean · CIK 0001877611 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2032-06-13

F1 · derivative.exercise_date: This Amendment No. 1 ("Form 4/A") to the Form 4 filed by the reporting person on June 16, 2022 (the "Original Form 4") is being filed to correct an administrative error, resulting in the incorrect versting schedule being included for the option. As reflected in this Form 4/A, the option vests as follows: (i) 50% on the first anniversary of the grant date, (ii) 25% on the second anniversary of the grant date, and (iii) 25% on the third anniversary of the grant date.

Read SEC document
June 14, 2022 Filed Jun 21, 2022 21:24 UTC Amendment GrantEmployee Stock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $1.75 $0.00
Disclosure

SEC source: 0001104659-22-073073 · tm2218957-3_4aseq1.xml · derivative · entry 1

Bolton Sheryle · CIK 0001418947 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2032-06-13

F1 · derivative.exercise_date: This Amendment No. 1 ("Form 4/A") to the Form 4 filed by the reporting person on June 16, 2022 (the "Original Form 4") is being filed to correct an administrative error, resulting in the incorrect versting schedule being included for the option. As reflected in this Form 4/A, the option vests as follows: (i) 50% on the first anniversary of the grant date, (ii) 25% on the second anniversary of the grant date, and (iii) 25% on the third anniversary of the grant date.

Read SEC document
June 14, 2022 Filed Jun 21, 2022 21:23 UTC Amendment GrantEmployee Stock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $1.75 $0.00
Disclosure

SEC source: 0001104659-22-073071 · tm2218957-2_4aseq1.xml · derivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2032-06-13

F1 · derivative.exercise_date: This Amendment No. 1 ("Form 4/A") to the Form 4 filed by the reporting person on June 16, 2022 (the "Original Form 4") is being filed to correct an administrative error, resulting in the incorrect versting schedule being included for the option. As reflected in this Form 4/A, the option vests as follows: (i) 50% on the first anniversary of the grant date, (ii) 25% on the second anniversary of the grant date, and (iii) 25% on the third anniversary of the grant date.

Read SEC document
May 16, 2022 Filed Feb 14, 2023 23:34 UTC OtherCommon Stock 15,111 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-005056 · doc5.xml · nonDerivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Drexler Family Trust U/D/T dated May 23, 1996

Disclosed balance after: 18,076

F1 · kind: Represents a pro rata distribution from Astia Angels Tivic LLC, of which the reporting person was a member, in connection with the dissolution of such entity.

F1 · price: Represents a pro rata distribution from Astia Angels Tivic LLC, of which the reporting person was a member, in connection with the dissolution of such entity.

F2 · ownership.nature: These shares are owned directly by the Drexler Family Trust U/D/T dated May 23, 1996, and indirectly by the reporting person as trustee of such trust.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 17:15 UTC
Cai VeronicaChief Financial Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 117,880 $0.00 Strike: $1.61 $0.00
Disclosure

SEC source: 0001104659-22-042855 · tm2211723d2_4.xml · derivative · entry 1

Cai Veronica · CIK 0001801322 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,880

Underlying: Common Stock · 117,880 shares

Expires 2032-03-31

F1 · derivative.exercise_date: The option vests as follows: (i) 25% one year from the grant date, and (ii) the remaining 75% in equal monthly installments over the 36 months thereafter.

Read SEC document
February 04, 2022 Filed Feb 8, 2022 17:34 UTC
Ernst JenniferDirector · Chief Executive Officer · 10% owner
GrantEmployee Stock Option (Right to Buy) · Derivative 200,000 $0.00 Strike: $1.83 $0.00
Disclosure

SEC source: 0001104659-22-014166 · tm225821d2_4.xml · derivative · entry 1

Ernst Jennifer · CIK 0001889915 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2027-02-03

F1 · derivative.exercise_date: The option vests as follows: (i) 25% one year from the grant date, and (ii) the remaining 75% in equal monthly installments over the next 36 months.

Read SEC document
February 04, 2022 Filed Feb 8, 2022 22:35 UTC
Sabia RyanChief Operating Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $1.67 $0.00
Disclosure

SEC source: 0001104659-22-014171 · tm225821d3_4.xml · derivative · entry 1

Sabia Ryan · CIK 0001892415 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2032-02-03

F1 · derivative.exercise_date: The option vests as follows: (i) 25% one year from the grant date, and (ii) the remaining 75% in equal monthly installments over the next 36 months.

Read SEC document
February 04, 2022 Filed Feb 8, 2022 22:32 UTC
Gurfein BlakeChief Scientific Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 35,000 $0.00 Strike: $1.67 $0.00
Disclosure

SEC source: 0001104659-22-014161 · tm225821d1_4.xml · derivative · entry 1

Gurfein Blake · CIK 0001891888 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2032-02-03

F1 · derivative.exercise_date: The option vests as follows: (i) 25% one year from the grant date, and (ii) the remaining 75% in equal monthly installments over the next 36 months.

Read SEC document
December 14, 2021 Filed Dec 16, 2021 20:38 UTC
Zikria DeanDirector
GrantEmployee Stock Option (Right to Buy) · Derivative 18,000 $0.00 Strike: $4.59 $0.00
Disclosure

SEC source: 0001104659-21-150713 · tm2135733d3_4.xml · derivative · entry 1

Zikria Dean · CIK 0001877611 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2031-12-13

F1 · derivative.exercise_date: The option will vest one year from the grant date.

Read SEC document
December 14, 2021 Filed Dec 17, 2021 01:37 UTC GrantEmployee Stock Option (Right to Buy) · Derivative 18,000 $0.00 Strike: $4.59 $0.00
Disclosure

SEC source: 0001104659-21-150711 · tm2135733d1_4.xml · derivative · entry 1

Bolton Sheryle · CIK 0001418947 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2031-12-13

F1 · derivative.exercise_date: The option will vest one year from the grant date.

Read SEC document
December 14, 2021 Filed Dec 17, 2021 01:39 UTC GrantEmployee Stock Option (Right to Buy) · Derivative 18,000 $0.00 Strike: $4.59 $0.00
Disclosure

SEC source: 0001104659-21-150715 · tm2135733d5_4.xml · derivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2031-12-13

F1 · derivative.exercise_date: The option will vest one year from the grant date.

Read SEC document
December 14, 2021 Filed Dec 17, 2021 01:38 UTC
Gurfein BlakeChief Scientific Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 82,500 $0.00 Strike: $4.59 $0.00
Disclosure

SEC source: 0001104659-21-150714 · tm2135733d4_4.xml · derivative · entry 1

Gurfein Blake · CIK 0001891888 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,500

Underlying: Common Stock · 82,500 shares

Expires 2031-12-13

F1 · derivative.exercise_date: The option vests as follows: (i) 25% one year from the grant date, and (ii) the remaining 75% in equal monthly installments over the next 36 months.

Read SEC document
December 14, 2021 Filed Dec 17, 2021 01:37 UTC
Sabia RyanVP of Sales and Operations
GrantEmployee Stock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $4.59 $0.00
Disclosure

SEC source: 0001104659-21-150712 · tm2135733d2_4.xml · derivative · entry 1

Sabia Ryan · CIK 0001892415 · VP of Sales and Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2031-12-13

F1 · derivative.exercise_date: The option vests as follows: (i) 25% one year from the grant date, and (ii) the remaining 75% in equal monthly installments over the next 36 months.

Read SEC document
November 12, 2021 Filed Nov 15, 2021 21:11 UTC
Ernst JenniferDirector · Chief Executive Officer · 10% owner
ConversionConvertible Promissory Note · Derivative Not disclosed $0.00 Strike: $3.75 $101,200.00
Disclosure

SEC source: 0001104659-21-139507 · tm2133057-1_4seq1.xml · derivative · entry 4

Ernst Jennifer · CIK 0001889915 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 26,986 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: On November 12, 2021, in connection with the Issuer's IPO, the outstanding principal and accrued but unpaid interest of the Convertible Promissory Note (the "Note"), amounting to $100,000 and $1,200, respectively, automatically converted into an aggregate of 26,986 shares of the Issuer's common stock at a conversion price of $3.75 per share, which conversion price was equal to the IPO price per share of the issuer's common stock, less a 25% discount.

F2 · price: On November 12, 2021, in connection with the Issuer's IPO, the outstanding principal and accrued but unpaid interest of the Convertible Promissory Note (the "Note"), amounting to $100,000 and $1,200, respectively, automatically converted into an aggregate of 26,986 shares of the Issuer's common stock at a conversion price of $3.75 per share, which conversion price was equal to the IPO price per share of the issuer's common stock, less a 25% discount.

F2 · derivative.exercise_date: On November 12, 2021, in connection with the Issuer's IPO, the outstanding principal and accrued but unpaid interest of the Convertible Promissory Note (the "Note"), amounting to $100,000 and $1,200, respectively, automatically converted into an aggregate of 26,986 shares of the Issuer's common stock at a conversion price of $3.75 per share, which conversion price was equal to the IPO price per share of the issuer's common stock, less a 25% discount.

F3 · derivative.expiration_date: The Note was scheduled to mature on June 1, 2023.

Read SEC document
November 12, 2021 Filed Nov 15, 2021 21:11 UTC
Ernst JenniferDirector · Chief Executive Officer · 10% owner
ConversionSeries Seed-2 Convertible Preferred Stock · Derivative 5,566 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-139507 · tm2133057-1_4seq1.xml · derivative · entry 3

Ernst Jennifer · CIK 0001889915 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,391 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The shares 5,566 shares of Series Seed-2 Convertible Preferred Stock held by the Reporting Person automatically converted into 1,391 shares of the Issuer's common stock on November 12, 2021 in connection with the Issuer's initial public offering (the "IPO"). The Series Seed-2 Convertible Preferred Stock had no expiration date.

F1 · price: The shares 5,566 shares of Series Seed-2 Convertible Preferred Stock held by the Reporting Person automatically converted into 1,391 shares of the Issuer's common stock on November 12, 2021 in connection with the Issuer's initial public offering (the "IPO"). The Series Seed-2 Convertible Preferred Stock had no expiration date.

F1 · derivative.expiration_date: The shares 5,566 shares of Series Seed-2 Convertible Preferred Stock held by the Reporting Person automatically converted into 1,391 shares of the Issuer's common stock on November 12, 2021 in connection with the Issuer's initial public offering (the "IPO"). The Series Seed-2 Convertible Preferred Stock had no expiration date.

Read SEC document
November 12, 2021 Filed Nov 15, 2021 21:11 UTC
Ernst JenniferDirector · Chief Executive Officer · 10% owner
ConversionCommon Stock 26,986 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-139507 · tm2133057-1_4seq1.xml · nonDerivative · entry 2

Ernst Jennifer · CIK 0001889915 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,199,877

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: On November 12, 2021, in connection with the Issuer's IPO, the outstanding principal and accrued but unpaid interest of the Convertible Promissory Note (the "Note"), amounting to $100,000 and $1,200, respectively, automatically converted into an aggregate of 26,986 shares of the Issuer's common stock at a conversion price of $3.75 per share, which conversion price was equal to the IPO price per share of the issuer's common stock, less a 25% discount.

F2 · price: On November 12, 2021, in connection with the Issuer's IPO, the outstanding principal and accrued but unpaid interest of the Convertible Promissory Note (the "Note"), amounting to $100,000 and $1,200, respectively, automatically converted into an aggregate of 26,986 shares of the Issuer's common stock at a conversion price of $3.75 per share, which conversion price was equal to the IPO price per share of the issuer's common stock, less a 25% discount.

Read SEC document
November 12, 2021 Filed Nov 15, 2021 21:11 UTC
Ernst JenniferDirector · Chief Executive Officer · 10% owner
ConversionCommon Stock 1,391 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-139507 · tm2133057-1_4seq1.xml · nonDerivative · entry 1

Ernst Jennifer · CIK 0001889915 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,172,891

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The shares 5,566 shares of Series Seed-2 Convertible Preferred Stock held by the Reporting Person automatically converted into 1,391 shares of the Issuer's common stock on November 12, 2021 in connection with the Issuer's initial public offering (the "IPO"). The Series Seed-2 Convertible Preferred Stock had no expiration date.

F1 · price: The shares 5,566 shares of Series Seed-2 Convertible Preferred Stock held by the Reporting Person automatically converted into 1,391 shares of the Issuer's common stock on November 12, 2021 in connection with the Issuer's initial public offering (the "IPO"). The Series Seed-2 Convertible Preferred Stock had no expiration date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.